Avandia

Type: Product
Name: Avandia
First reported Jul 24 2014 - Updated Jul 24 2014 - 1 reports

Safety profile of blockbuster blood thinner comes under question

The BMJ probe also suggests that there may be safety benefits to monitoring Pradaxa's anticoagulant effect on individual patients -- a practice deemed unnecessary by the Food and Drug Administration when it approved the medication's marketing four years ... [Published Los Angeles Times - Jul 24 2014]
First reported Jul 24 2014 - Updated Jul 24 2014 - 1 reports

People with more brown fat better able to control blood sugar

Researchers have known that brown fat has an influence on metabolism but a recent study has shown that in addition to burning calories, brown fat can also help with . Researchers from the University of Texas Medical Branch (UTMB) reviewed the effects ... [Published Diabetes.co.uk - Jul 24 2014]
First reported Jul 24 2014 - Updated Jul 24 2014 - 1 reports

What Do We Want Out of Our Diabetes Treatments?

We want our diabetes treatments to be effective, but we also want them to be safe, and it is up to the FDA to decide if the benefits of a given medication outweigh the risks. Consider insulin: if misused, it can kill you, but its benefits – it keeps all ... [Published diaTribe - Jul 24 2014]
First reported Jul 18 2014 - Updated Jul 18 2014 - 1 reports

Database provides fresh evidence of effect of diabetes drugs on Alzheimer's

While clinical trials remain the gold standard for proving safety and efficacy, the scale, real-world mix of patients and relatively low costs associated with database-powered studies make them a useful option for researchers. This week a German team ... [Published Fierce Biotech IT - Jul 18 2014]
First reported Jul 18 2014 - Updated Jul 18 2014 - 1 reports

Attorney Bryan Schefman Wins in US Court of Appeals July 16, 2014:...

Attorney Bryan Schefman argued successfully for the right of medical providers to seek charges and double damages under the Medicare Secondary Payor (“MSP”) act where a no-fault insurer has denied PIP benefits to a Medicare eligible insured. The Court ... [Published PRWeb - Jul 18 2014]
First reported Jul 10 2014 - Updated Jul 10 2014 - 1 reports

Settlement Over Deceptive Implant Marketing

Johnson & Johnson (“J&J”) has reached a four million settlement with the state of Oregon to resolve allegations that J&J improperly marketed its DePuy ASR metal-on-metal hip implants.  J&J has recalled 93,000 ASR hip implants, which had a 12% failure ... [Published JD Supra - Jul 10 2014]
First reported Jun 20 2014 - Updated Jun 20 2014 - 1 reports

GlaxoSmithKline Fined Again – The Cost of Doing Business?

It is seen as the cost of doing business. It may be illegal, but is also highly profitable, so why stop?That seems to be the attitude of many pharmaceutical companies – and the latest proof of that comes in the form of a $105 million fine leveled against ... [Published JD Supra - Jun 20 2014]
First reported Jun 19 2014 - Updated Jun 19 2014 - 1 reports

Can pharma salvage its tarnished rep? Survey says yes

Drugmakers aren't the most admired of companies. Or the most respected, or even the most popular. Face it: If the pharma industry was in high school, it would be sitting alone in a corner of the cafeteria, or, on a good day, hanging out with Big Oil.Plenty ... [Published FiercePharma - Jun 19 2014]
First reported Jun 18 2014 - Updated Jun 19 2014 - 2 reports

GLAXOSMITHKLINE : Baron and Budd Reaches Settlement for Case Against Avandia Manufacturer GlaxoSmithKline

The national law firm of Baron and Budd has reached a $177 million settlement with GlaxoSmithKline on behalf of the states of Kentucky , Maryland , Mississippi , New Mexico , South Carolina , Utah and West Virginia regarding the deceptive advertising ... [Published 4 Traders - Jun 19 2014]
First reported Jun 16 2014 - Updated Jun 16 2014 - 1 reports

Baron and Budd reaches $177m settlement for seven states against GlaxoSmithKline

The national law firm of Baron and Budd has reached a $177 million settlement with GlaxoSmithKline on behalf of the states of Kentucky, Maryland, Mississippi, New Mexico, South Carolina, Utah and West Virginia regarding the deceptive advertising of the ... [Published Pharmaceutical Business Review - Jun 16 2014]
First reported Jun 13 2014 - Updated Jun 13 2014 - 6 reports

Baron and Budd Announces $177 Million Settlement for Seven States Against Avandia Manufacturer GlaxoSmithKline

DALLAS, Jun 13, 2014 (BUSINESS WIRE) -- The national law firm of Baron and Budd has reached a $177 million settlement with GlaxoSmithKline on behalf of the states of Kentucky, Maryland, Mississippi, New Mexico, South Carolina, Utah and West Virginia regarding ... [Published PharmaGossip - Jun 13 2014]
First reported Jun 03 2014 - Updated Jun 03 2014 - 1 reports

Permitted Gamesmanship v. Prohibited Conduct

br />!--[if gte mso 10]> /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-qformat:yes; mso-style-parent:""; ... [Published Drug and Device Law - Jun 03 2014]
Entities: Avandia, Fraud, State Court

Quotes

In an apparent bid to position Pradaxa as an improvement on a long-used medication, Boehringer-Ingelheim "withheld from the [FDA's] regulators important analyses regarding how to use the drug as safely and effectively as possible" wrote BMJ's investigations editor, Deborah Cohen
...Diseases concluded that long-term Actos use cuts the risk of dementia, but others have questioned the real-world significance of the results. "It's actually almost surprising to me that the lowering of relative risk was so weak" Boston University professor Ben Wolozin told Bloomberg...
...Ajani said there are many reasons why doing business in Italy is difficult but focused on one particular problem. "If you are not a friend of a friend, everything is difficult" he said. Having increased sales by 400% from 2006 to 2013, Cosmo is now looking to expand sales in the U S through its deal with Salix and bring its...
"Patient safety is our first priority and we are confident in the safety of the influenza vaccines we have provided to patients. Every batch of GSK vaccines is subject to extensive review before it is released. Vaccines that do not pass this rigorous review are discarded."

More Content

All (47) | News (33) | Reports (0) | Blogs (14) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
People with more brown fat better able to contr... [Published Diabetes.co.uk - Jul 24 2014]
What Do We Want Out of Our Diabetes Treatments? [Published diaTribe - Jul 24 2014]
Safety profile of blockbuster blood thinner com... [Published Los Angeles Times - Jul 24 2014]
5 More Possible Partners For MannKind's Afrezza... [Published Seeking Alpha - Jul 21 2014]
Database provides fresh evidence of effect of d... [Published Fierce Biotech IT - Jul 18 2014]
Attorney Bryan Schefman Wins in US Court of App... [Published PRWeb - Jul 18 2014]
U.K. gov names ex-biotech VC as life sci chief,... [Published FierceBiotech - Jul 18 2014]
FDA Once Again Reaches Conclusions At Odds With... [Published Forbes.com - Jul 14 2014]
Settlement Over Deceptive Implant Marketing [Published JD Supra - Jul 10 2014]
Status Conference Regarding Risperdal Litigatio... [Published PRWeb - Jul 08 2014]
Baron and Budd Now Accepting Cases Involving De... [Published PRWeb - Jul 07 2014]
The Lab for These FDA Scientists Is a Computer ... [Published U.S. Food and Drug Administration - Jul 01 2014]
GlaxoSmithKline to Pay $105 Million to Settle C... [Published PRWeb - Jun 27 2014]
Study Reveals How Omega-3′s Provide Protection ... [Published Daily Times Nigeria - Jun 27 2014]
FDA orders GlaxoSmithKline to review manufactur... [Published Guardian.co.uk - Jun 24 2014]
New Order Issued, Paving the Way for Federal Li... [Published PRWeb - Jun 23 2014]
More Than 1,700 GranuFlo Cases Filed in Federal... [Published PRWeb - Jun 21 2014]
GlaxoSmithKline Fined Again – The Cost of Doing... [Published JD Supra - Jun 20 2014]
Can pharma salvage its tarnished rep? Survey sa... [Published FiercePharma - Jun 19 2014]
GLAXOSMITHKLINE : Baron and Budd Reaches Settle... [Published 4 Traders - Jun 19 2014]
June 19 - Diabetes Medication [Published WMDT ABC-47 - Jun 18 2014]
Status Conference on GranuFlo Lawsuits Held, Ba... [Published PRWeb - Jun 18 2014]
GLAXOSMITHKLINE : Baron and Budd Garners Settle... [Published 4 Traders - Jun 18 2014]
Global type 2 diabetes pharmaceutical market to... [Published PR inside - Jun 17 2014]
Baron and Budd reaches $177m settlement for sev... [Published Pharmaceutical Business Review - Jun 16 2014]
Baron and Budd Announces $177 Million Settlemen... [Published PharmaGossip - Jun 13 2014]
Baron and Budd Announces $177 Million Settlemen... [Published EON Business - Jun 13 2014]
Baron and Budd Announces $177 Million Settlemen... [Published Business Wire Photo/Multimedia News - Jun 13 2014]
Baron and Budd Announces $177 Million Settlemen... [Published Business Wire Professional Services News - Jun 13 2014]
Baron and Budd Announces $177 Million Settlemen... [Published Business Wire Health News - Jun 13 2014]
1 2
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Baron and Budd Announces $177 Million Settlemen... [Published PharmaGossip - Jun 13 2014]
DALLAS, Jun 13, 2014 (BUSINESS WIRE) -- The national law firm of Baron and Budd has reached a $177 million settlement with GlaxoSmithKline on behalf of the states of Kentucky, Maryland, Mississippi, New Mexico, South Carolina, Utah and West Virginia regarding ...
Baron and Budd Announces $177 Million Settlemen... [Published EON Business - Jun 13 2014]
DALLAS--(EON: Enhanced Online News)--The national law firm of Baron and Budd has reached a $177 million settlement with GlaxoSmithKline on behalf of seven states. ...
Baron and Budd Announces $177 Million Settlemen... [Published Business Wire Photo/Multimedia News - Jun 13 2014]
DALLAS--(BUSINESS WIRE)--The national law firm of Baron and Budd has reached a $177 million settlement with GlaxoSmithKline on behalf of seven states. ...
Baron and Budd Announces $177 Million Settlemen... [Published Business Wire Professional Services News - Jun 13 2014]
DALLAS--(BUSINESS WIRE)--The national law firm of Baron and Budd has reached a $177 million settlement with GlaxoSmithKline on behalf of seven states. ...
Baron and Budd Announces $177 Million Settlemen... [Published Business Wire Health News - Jun 13 2014]
DALLAS--(BUSINESS WIRE)--The national law firm of Baron and Budd has reached a $177 million settlement with GlaxoSmithKline on behalf of seven states. ...
1 2 3
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.